Eloxx Pharmaceuticals is a startup based in the United States, 2 tracked investors.
Based in the United States, Eloxx Pharmaceuticals is a startup founded in 2014. Brouky records 2 investors associated with the company.
Eloxx Pharmaceuticals develops small molecule genetic therapies targeting nonsense mutations for rare genetic diseases such as Alport Syndrome, using proprietary platform technologies including TURBO-ZM™ and Ribosome Modulating Agents.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.